| Indian generic drug manufacturer Dr. Reddy’s Laboratories, is undertaking a $16.5 million expansion of its plant in Shreveport. La.
The state is providing sales tax abatement and a $2.1 million capital grant to the company, which is expected to add 73 new jobs beyond the 161 already at the company. Its Shreveport plant is the largest producer of the burn remedy, silver sulfadiazine cream, and the second-largest producer of ibuprofen in North America. |